Clinical Effect of Naomaitong in Treating Cerebrovascular Diseases
Objective: To explore the clinical effect of applying Naomaitong in the treatment of cerebrovascular diseases. Method: The research work was carried out in our hospital from November 2018 to November 2019. A total of 100 patients were selected in this study, all of whom were cerebrovascular disease...
Main Authors: | Zhang Wentao, Zuo Ping, Wang Feng, Cui Yinglin |
---|---|
Format: | Article |
Language: | English |
Published: |
EDP Sciences
2020-01-01
|
Series: | E3S Web of Conferences |
Online Access: | https://www.e3s-conferences.org/articles/e3sconf/pdf/2020/78/e3sconf_iseese2020_03008.pdf |
Similar Items
-
Proteomic Assessment of iTRAQ-Based NaoMaiTong in the Treatment of Ischemic Stroke in Rats
by: Kening Li, et al.
Published: (2019-01-01) -
Clinical Study on Treatment of Patients with Acute Cerebral Infarction by Huayu Tongluo Decoction Combined with Edaravone Injection
by: Zhang Wentao, et al.
Published: (2020-01-01) -
Research progress of clinical study on cerebrovascular disease
by: Yan-ping JIANG, et al.
Published: (2018-02-01) -
Clinical trials in cerebrovascular disease
by: Murphy, Jeremy James
Published: (1991) -
Clinic Practical Guides for Cerebrovascular Diseases
by: Miguel Angel Buergo Zuaznábar, et al.
Published: (2007-05-01)